Radiation Therapy

The radiation therapy channel covers all aspects of radiation oncology technology. Radiation therapy includes linear accelerators (LINAC), proton therapy, brachytherapy, image guided radiation therapy (IGRT), focused ultrasound, stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), treatment planning systems and tomotherapy.

Varian Drives Next Evolution of Proton Treatment Planning with Eclipse v16.1
News | Treatment Planning | September 15, 2020
Varian's Proton Therapy Treatment Planning Software Clears FDA
September 15, 2020 — Varian announced it has received FDA 510(k) clearance for its Eclipse v16.1 treatment planning...
read more
Sandra Sha, M.D., a distinguished physician as recognized by the Florida Medical Association, specializing in breast cancer treatment

Sandra Sha, M.D.

News | Brachytherapy Systems, Women's Healthcare | September 08, 2020
Florida Cancer Center Upgrades to AccuBoost Digital
September 8, 2020 — Advanced Radiation Therapy has completed the installation of the AccuBoost Digital platform at the...
read more
the Contrast Media Injectors Market is estimated to be USD 1.3 billion in 2020 and  projected to reach $1.9B by 2025, at a CAGR of 7.4% between 2020 and 2025

Getty Images

News | Contrast Media Injectors | September 02, 2020
Contrast Media Injectors Market Projected at $1.9 billion by 2025
September 2, 2020 — According to the new market research report "Contrast Media Injectors Market By Product (Injector...
read more
Single-dose radiotherapy replaces need for extra hospital visits, with benefits for patient safety and well-being

Getty Images

News | Women's Health | August 20, 2020
Single Dose Radiotherapy as Good as Conventional Therapy for Most With Early Breast Cancer
August 20, 2020— For most women with early breast cancer, a single dose of targeted radiotherapy during surgery is just...
read more
Public health screening guidelines for lung cancer followed by the United States Preventive Services Task Force (USPSTF) and the Center for Medicare and Medicaid Services (CMS) undercount African Americans, contributing to disparities in lung cancer screening and treatment, according to a study published today in the Journal of Thoracic Oncology.

Getty Images

News | Lung Imaging | August 19, 2020
Current Lung Cancer Public Health Screening Guidelines Under Count African Americans
August 19, 2020 — Public health screening guidelines for lung cancer followed by the United States Preventive Services...
read more
A special issue of the Journal of Medical Imaging and Radiation Sciences features stories about the interpersonal skills beyond the technical aspects to care for and guide patients through medical imaging and radiation therapy procedures

Image courtesy of Canon

News | Patient Engagement | August 11, 2020
Patient Experiences in Medical Imaging and Radiation Therapy
August 11, 2020 — "I went into the MRI bracing for the wave of panic I knew would come as soon as I was strapped down...
read more
Global radiotherapy market revenue is set to expand from $7,222.4 million in 2019 to $17,194.4 million by 2030, at an 8.4% CAGR between 2020 and 2030, the key factor driving the market growth is the increasing number of cancer cases, according to the report published by P&S Intelligence.

Image courtesy of Elekta

News | Radiation Therapy | August 06, 2020
Radiotherapy Market to Cross $17 Million Revenue by 2030
August 6, 2020 — Global radiotherapy market revenue is set to expand from $7,222.4 million in 2019 to $17,194.4 million...
read more
Siemens AG is continuing to rigorously execute its Vision 2020+ strategy and therefore expressly welcomes Siemens Healthineers AG’s acquisition of a 100 percent stake in Varian Medical Systems, Inc., a U.S. company active in the area of cancer research and therapy.

Getty Images

News | Radiology Business | August 03, 2020
Siemens Healthineers Set to Acquire Varian in $16.4B Deal
August 3, 2020 — Siemens AG is continuing to rigorously execute its Vision 2020+ strategy and therefore expressly...
read more
JAMA Oncol. Published online July 30, 2020. doi:10.1001/jamaoncol.2020.2783

Table 1. JAMA Oncol. Published online  July 30, 2020. doi:10.1001/jamaoncol.2020.2783

News | Coronavirus (COVID-19) | July 31, 2020
Outcomes in Radiotherapy-treated Patients with Cancer During COVID-19
July 31, 2020 — An article published in JAMA Oncology addresses the delivery of radiotherapy in 209 patients with...
read more
Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, and ImaginAb, Inc., a company that harnesses the specificity of monoclonal antibodies, have entered into a collaboration agreement to develop new targeted theranostic (diagnostic and therapy) products for a broad range of cancer types.
News | Radiation Oncology | July 29, 2020
Clarity Pharmaceuticals and ImaginAb Collaborate on New Cancer Targets
July 29, 2020 — Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, and...
read more
It has been estimated that the overwhelming focus on COVID-19 could cause up to 35,000 excess cancer deaths in the UK during the next 12 months, and  Zegami, the Oxford University data visualization spin-out which has worked on several projects focused on the detection, diagnosis, or management of cancer, is calling for greater use of technology to speed up the process of diagnosis and treatment.

Getty Images

News | Radiation Oncology | July 29, 2020
Better Use of Technology Needed to Address Coronavirus-fueled Backlog in Cancer Diagnosis
July 29, 2020 — It has been estimated that the overwhelming focus on COVID-19 could cause up to 35,000 excess cancer...
read more
In I-131 cancer therapy, decay events damage sensitive DNA within a tumor cell nucleus, causing catastrophic single and double strand breaks. Clinical use of antibody-delivered Auger emitters could open a window for the targeted destruction of extracellular COVID-19 virions, decreasing the viral load during active infection and potentially easing the disease burden for a patient. View all figures from this study. http://jnm.snmjournals.org/content/early/2020/07/16/jnumed.120.249748.full.pdf+html

In I-131 cancer therapy, decay events damage sensitive DNA within a tumor cell nucleus, causing catastrophic single and double strand breaks. Clinical use of antibody-delivered Auger emitters could open a window for the targeted destruction of extracellular COVID-19 virions, decreasing the viral load during active infection and potentially easing the disease burden for a patient. View all figures from this study.

 

News | Coronavirus (COVID-19) | July 22, 2020 | Dave Fornell, Editor
Radiation Therapy Might be a Treatment Option for COVID-19
July 22, 2020 — One of the first studies has been published that looks at the use of radiation therapy to help treat...
read more
 A Ludwig Cancer Research study has dissected how radiotherapy alters the behavior of immune cells known as macrophages found in glioblastoma (GBM) tumors and shown how these cells might be reprogrammed with an existing drug to suppress the invariable recurrence of the aggressive brain cancer.
News | Radiation Therapy | July 22, 2020
Study Finds Reprogramming of Immune Cells Enhances Effects of Radiotherapy in Preclinical Models of Brain Cancer
July 22, 2020 — A Ludwig Cancer Research study has dissected how radiotherapy alters the behavior of immune cells known...
read more
World's largest radiation oncology meeting will offer full conference on interactive platform October 25-28, 2020
News | ASTRO | July 09, 2020
ASTRO to Host Virtual Annual Meeting in October
July 9, 2020 — Registration opens today for the American Society for Radiation Oncology's (ASTRO) 62nd Annual Meeting,...
read more
At the American Association of Physicists in Medicine (AAPM) 2019 meeting, new artificial intelligence (AI) software to assist with radiotherapy treatment planning systems was highlighted. The goal of the AI-based systems is to save staff time, while still allowing clinicians to do the final patient review. 
Feature | Treatment Planning | July 08, 2020 | By Melinda Taschetta-Millane
Integrating Artificial Intelligence in Treatment Planning
At the American Association of Physicists in Medicine (AAPM) 2019 meeting, new artificial intelligence (AI) software to...
read more
Radiotherapy has been used to treat cancers for more than a century and continues to be utilized in cancer treatment plans today. Since the introduction of radiotherapy, clinicians have been working tirelessly to further refine treatments to better target cancer.
Feature | Radiation Therapy | July 06, 2020 | By Yves Archambault
Adaptive Therapy Today
Everything has room for improvement, right? Right. When it comes to cancer care, it is no different. Researchers, drug...
read more
Proton therapy has evolved, and future predictions include smaller systems, more sophisticated proton dosimetry and devices that manipulate the proton beam
Feature | Proton Therapy | July 06, 2020 | By Minesh Mehta, M.D.
Proton Therapy Predictions for the Next Decade
The field of proton therapy is continuing to see explosive growth. In the past decade alone, technological advances...
read more
Advanced Radiation Therapy has completed the first AccuBoost Digital installation at Rhode Island Hospital (RIH). This state-of-the-art platform leverages the superior resolution of digital mammography in the delivery of breast radiation therapy.
News | Breast Imaging | July 06, 2020
First AccuBoost Digital Installation for Radiation Treatment of Breast Cancer
July 6, 2020 — Advanced Radiation Therapy has completed the first AccuBoost Digital installation at Rhode Island...
read more
 Accuray Incorporated announced the company has launched the CyberKnife S7 System, an innovative device combining speed, advanced precision and real-time artificial intelligence (AI)-driven motion tracking and synchronization treatment delivery for all stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments — in as little as 15 minutes.
News | Stereotactic Body Radiation Therapy (SBRT) | June 26, 2020
Accuray Launches New CyberKnife S7 System
June 26, 2020 — Accuray Incorporated announced the company has launched the CyberKnife S7 System, an innovative device...
read more
Neurosurgeon Jason Sheehan, M.D., Ph.D., of UVA Health, is pioneering the use of focused ultrasound to treat glioblastoma, the deadliest brain tumor. Image courtesy of UVA Health

Neurosurgeon Jason Sheehan, M.D., Ph.D., of UVA Health, is pioneering the use of focused ultrasound to treat glioblastoma, the deadliest brain tumor. Image courtesy of UVA Health

News | Focused Ultrasound Therapy | June 23, 2020
Focused Ultrasound Shows Promise Against Deadliest Brain Tumor
June 23, 2020 — An innovative use of focused ultrasound being pioneered at the University of Virginia School of...
read more
© Copyright Wainscot Media. All Rights Reserved.